Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million
05/08/2026 21:06
BRIEF-GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million Aug 05 (Reuters) - GoodRx Holdings Q2 revenue USD 200.4 million vs. IBES estimate USD 193.2 million.
- Q2 adjusted EBITDA USD 63.7 million vs. IBES estimate USD 59.8 million
- Q2 adjusted EBITDA margin 31.8%
- Q2 net income USD 8.5 million
Recent news on GoodRx Holdings
See all newsAmazon, GoodRx target US prescription subscribers as health insurance coverage slips
GoodRx offers health subscription for families, to launch as employee benefit in 2027
GoodRx Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary
GoodRx Q2 revenue beats estimates; raises 2026 outlook
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 26.8 Million Vs. IBES Estimate USD 27.2 Million